ID23735A - Tablet trovafloksasin mesilat - Google Patents

Tablet trovafloksasin mesilat

Info

Publication number
ID23735A
ID23735A IDP990036D ID990036D ID23735A ID 23735 A ID23735 A ID 23735A ID P990036 D IDP990036 D ID P990036D ID 990036 D ID990036 D ID 990036D ID 23735 A ID23735 A ID 23735A
Authority
ID
Indonesia
Prior art keywords
trovafloksasin
mesilat
tablet
trovafloksasin mesilat
tablet trovafloksasin
Prior art date
Application number
IDP990036D
Other languages
English (en)
Inventor
Alton Dale Johnson
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23735A publication Critical patent/ID23735A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP990036D 1998-01-21 1999-01-15 Tablet trovafloksasin mesilat ID23735A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
ID23735A true ID23735A (id) 2000-05-11

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990036D ID23735A (id) 1998-01-21 1999-01-15 Tablet trovafloksasin mesilat

Country Status (34)

Country Link
US (1) US6187341B1 (id)
EP (1) EP0930068A3 (id)
JP (1) JPH11269072A (id)
KR (1) KR100314977B1 (id)
CN (1) CN1227743A (id)
AP (1) AP1094A (id)
AR (1) AR012780A1 (id)
AU (1) AU758381B2 (id)
BG (1) BG103106A (id)
BR (1) BR9900116A (id)
CA (1) CA2259698C (id)
CO (1) CO4810225A1 (id)
DZ (1) DZ2712A1 (id)
EA (1) EA003247B1 (id)
GT (1) GT199900004A (id)
HR (1) HRP990023A2 (id)
HU (1) HUP9900154A3 (id)
ID (1) ID23735A (id)
IL (1) IL128051A0 (id)
IS (1) IS4947A (id)
MA (1) MA24747A1 (id)
NO (1) NO990243L (id)
NZ (1) NZ333838A (id)
OA (1) OA10958A (id)
PA (1) PA8466701A1 (id)
PE (1) PE20000169A1 (id)
PL (1) PL330981A1 (id)
SG (1) SG70666A1 (id)
SK (1) SK4299A3 (id)
TN (1) TNSN99007A1 (id)
TR (1) TR199900089A2 (id)
TW (1) TW518224B (id)
YU (1) YU2399A (id)
ZA (1) ZA99393B (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE279193T1 (de) * 1998-11-10 2004-10-15 Bayer Healthcare Ag Pharmazeutische zubereitung von moxifloxacin
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
CA2508792C (en) 2002-12-06 2013-02-05 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
US20050019397A1 (en) * 2003-07-23 2005-01-27 Jacobs Richard L. Cellulosic fiber containing composition
CA2568914C (en) 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
AU2005295482B2 (en) * 2004-10-15 2011-03-31 Supernus Pharmaceuticals Inc. Less abusable pharmaceutical preparations
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
SMT201900411T1 (it) 2012-06-19 2019-09-09 Debiopharm Int Sa Derivati di profaramci di (e)-n-metil-n-((3-metilbenzofuran-2-il)metil -3-(7-osso-5,6,7,8-tetraidro-1,8-naftiridin-3-il)acrilammide
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
FI3923914T3 (fi) 2019-02-14 2023-04-27 Debiopharm Int Sa Afabisiiniformulaatio, menetelmä sen valmistamiseksi
MA56184A (fr) 2019-06-14 2022-04-20 Debiopharm Int Sa Afabicine pour utilisation dans le traitement d'infections bactériennes impliquant un biofilm
JP2025529185A (ja) * 2022-08-30 2025-09-04 パンネックス セラピューティクス インコーポレイテッド パネキシン-1調節剤及びパネキシン-1が関与する疾患の治療方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
NZ312199A (en) * 1995-08-29 1999-06-29 Pfizer Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
DZ2712A1 (fr) 2003-09-01
PA8466701A1 (es) 2000-09-29
SG70666A1 (en) 2000-02-22
KR100314977B1 (ko) 2001-11-24
JPH11269072A (ja) 1999-10-05
HRP990023A2 (en) 1999-08-31
HUP9900154A3 (en) 2000-12-28
AU1217399A (en) 1999-08-12
CO4810225A1 (es) 1999-06-30
US6187341B1 (en) 2001-02-13
CA2259698C (en) 2003-04-15
IS4947A (is) 1999-07-22
AR012780A1 (es) 2000-11-08
OA10958A (en) 2001-10-31
HUP9900154A2 (hu) 1999-09-28
AP9901443A0 (en) 1999-03-31
BR9900116A (pt) 2000-05-02
KR19990068014A (ko) 1999-08-25
EA199900046A3 (ru) 1999-12-29
GT199900004A (es) 2000-07-08
CA2259698A1 (en) 1999-07-21
AU758381B2 (en) 2003-03-20
PE20000169A1 (es) 2000-03-10
BG103106A (en) 1999-08-31
EP0930068A2 (en) 1999-07-21
EA199900046A2 (ru) 1999-08-26
TR199900089A3 (tr) 1999-10-21
AP1094A (en) 2002-08-19
NZ333838A (en) 2000-03-27
TR199900089A2 (xx) 1999-10-21
HU9900154D0 (en) 1999-03-29
PL330981A1 (en) 1999-08-02
IL128051A0 (en) 1999-11-30
EA003247B1 (ru) 2003-02-27
CN1227743A (zh) 1999-09-08
NO990243L (no) 1999-07-22
ZA99393B (en) 2000-07-21
SK4299A3 (en) 2000-06-12
YU2399A (sh) 2002-06-19
TW518224B (en) 2003-01-21
NO990243D0 (no) 1999-01-20
TNSN99007A1 (fr) 2005-11-10
EP0930068A3 (en) 1999-12-22
MA24747A1 (fr) 1999-10-01

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
DE59911453D1 (de) Aktivkohlefilter
IS5869A (is) Hraðlosandi tafla
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
DE59907306D1 (de) Fadenchangierung
DE59906931D1 (de) Exzenterzahnradgetriebe
IS4947A (is) Tróvafloxasín mesýlat tafla
ATE262513T1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
ATE237529T1 (de) Tablettenspender
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
EP1074250A4 (en) SUGAR-COATED TABLETS
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59908057D1 (de) Underdruckhandhabungseinrichung
DE59807217D1 (de) Nadellager
DE59808995D1 (de) Endomikroskopsystem
DE19842103B4 (de) Stanznietzuführung
DK1051156T3 (da) Farmaceutiske præparater
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59902088D1 (de) Achrathermer Reimager
DE59903616D1 (de) Rollenwicklerwalze
DE59901263D1 (de) Einzelplatz-sortierer
DE59910491D1 (de) Umlufttrockner